visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Delcath Systems, Inc

    Get Full Access

    Description

    • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO includes the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma; and the ALIGN trial, a Phase 3 clinical trial for intrahepatic cholangiocarcinoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
    • location

      Headquarters:1633 Broadway , New York, New York, United States

      More
    • Delcath Systems, Inc phone

      Phone Number: +1 212-489-2100

    • Delcath Systems, Inc website

      Website: https://www.delcath.com

    • Delcath Systems, Inc employees

      Employees:37

    • Delcath Systems, Inc revenue

      Revenue:$1 - 10M

    • Delcath Systems, Inc legal name

      Legal Name:Delcath Systems, Inc

    • Delcath Systems, Inc's Social Media

      Delcath Systems, Inc linkedin Delcath Systems, Inc twitter
    • done Is this data correct?

    • |  NAICS Code: 339112  |

        NYSE: DCTH

      Show More
    Person level website identification

    Executive Chairman for Delcath Systems, Inc

    Roger Stoll

    Executive Chairman

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Roger Stoll

    Executive Chairman

    Kris Kandarpa

    Executive Vice President

    Kevin Muir

    Vice President, Commercial Operations

    Karin Radovich

    Director, Regulatory Affairs And Quality Assurance

    Michael Leen

    Emea Managing Director

    Frequently Asked Questions regarding Delcath Systems, Inc

    • Where are Delcath Systems, Inc's Headquarters?

      Delcath Systems, Inc's Headquarters are in 1633 Broadway ,New York,New York,United States

    • What is Delcath Systems, Inc's phone number?

      Delcath Systems, Inc's phone number is +1 212-489-2100

    • What is Delcath Systems, Inc's stock symbol?

      Delcath Systems, Inc's stock symbol is DCTH

    • What is Delcath Systems, Inc's official website?

      Delcath Systems, Inc's official website is https://www.delcath.com

    • What is Delcath Systems, Inc's Revenue?

      Delcath Systems, Inc's revenue is $1 - 10M

    • What is Delcath Systems, Inc's NAICS code?

      Delcath Systems, Inc's NAICS code is 339112

    • How many employees are working in Delcath Systems, Inc

      Delcath Systems, Inc has 37 employees

    • What is Delcath Systems, Inc's Industry?

      Delcath Systems, Inc is in the industry of Pharmaceuticals

    Company Directory